How to prioritise longevity interventions after 40

Text written with the help of AI.

Most longevity choices compete for limited time and attention. A treatment may change a blood test, and a practice may improve a physiological measurement, without showing that either helps people stay mobile, feel better or avoid illness. Prioritising after 40 starts with the outcome you want to protect.

Ask what benefit was measured

For any proposed intervention, ask: compared with what, which outcome improved, and in whom? A comparison with inactivity does not show that a practice adds value to an existing exercise programme. A result in older adults with physical limitations does not predict an individual result for a healthy 45-year-old.

Peter Attia’s essay on prioritising interventions raises the question of how a practice earns a place in a finite health budget. The distinction between a measurement and a benefit helps answer it.

The TRUST trial enrolled 737 adults aged 65 or older with persistent subclinical hypothyroidism: elevated thyroid-stimulating hormone (TSH) and free thyroxine within the reference range. After one year, levothyroxine lowered TSH more than placebo but did not improve the trial’s primary outcomes of hypothyroid symptoms and tiredness. TRUST Study Group, 2017. This finding concerns older adults with subclinical disease and a modest average TSH elevation. It does not settle treatment for overt thyroid disease or justify changing a prescription independently.

A measurement can also have clinical-outcome evidence behind a particular treatment strategy. In SPRINT, 9,361 people at increased cardiovascular risk, without diabetes or previous stroke, were assigned to different blood-pressure treatment targets. The final report found fewer major cardiovascular events and deaths with intensive treatment during the trial. SPRINT Research Group, 2021. Those findings do not mean every lower reading is better for every person, or that any method of lowering blood pressure inherits the trial’s benefits. Individual targets require clinical judgement.

Protect the activities with demonstrated benefits

The LIFE trial studied an outcome many people would recognise as consequential: losing the ability to walk 400 metres. It enrolled 1,635 sedentary adults aged 70 to 89 who had physical limitations but could initially complete that walk. Participants received either a structured programme of walking, resistance and flexibility exercise or health education. Over an average 2.6 years, major mobility disability occurred in 30.1% of the activity group and 35.5% of the education group. Pahor and colleagues, 2014.

The 5.4-percentage-point difference is a result for this study population, not a forecast for every adult over 40. Its importance is the outcome measured: a defined loss of mobility, rather than a laboratory proxy.

For adults more broadly, WHO recommends 150 to 300 minutes of moderate aerobic activity a week, or 75 to 150 minutes of vigorous activity, alongside muscle-strengthening activity on at least two days. These are population guidelines to adapt to ability and circumstances; some activity is better than none. Before adding another longevity practice, it is worth knowing what activity and strengthening already fit into your week.

Where heat research stands

Heat exposure is an interesting area of emerging evidence, but the benefit shown depends on what a study measured. In a 2026 trial, 31 inactive adults with overweight or obesity, with an average age of 58, were randomised to cycling, hot-water immersion or an inactive control group for 12 weeks. Researchers measured flow-mediated dilation: an ultrasound assessment of how an artery widens in response to increased blood flow.

Arm-artery responses increased with cycling and immersion, with no statistically significant difference detected between them. Exercise improved responses relative to control in both arm and leg arteries; immersion did not establish the same pattern. The trial found no significant effects on resting blood pressure or arterial stiffness. Costa and colleagues, 2026.

A small trial’s failure to detect a difference does not establish that heat and exercise are equivalent. Nor did these measurements show fewer cardiovascular events, preserved independence or longer life. They are insufficient grounds for replacing exercise with heat exposure.

Suitability matters too. CDC guidance identifies medications, including diuretics, that can increase vulnerability to heat through dehydration and related effects. Anyone concerned about a medication should discuss deliberate heat exposure with a clinician rather than stop the medication independently.

Leave room for preference without claiming a longevity benefit

Personal observation can tell you whether an optional practice is enjoyable, affordable and compatible with your routine. It cannot establish that you are ageing more slowly. Feeling relaxed after a bath, for example, is a reason to value the experience; it is not evidence of a vascular or lifespan benefit.

The next choice is partly about opportunity cost. If an optional practice would displace your only opportunities for physical activity, the evidence above supports protecting those opportunities. If it fits comfortably and is suitable for your circumstances, you need not claim a longevity benefit to choose it.

Before committing time or money, write down the outcome you want, the evidence connecting the practice to that outcome, and what it would replace. When the claimed benefit remains unmeasured, keeping an intervention on the reading list is a reasonable decision.

Sources